4
Changes in Ownership
Mirum Pharmaceuticals, Inc. Filed Acc 0001415889-25-001951
Options or other derivatives
- CHIEF EXECUTIVE OFFICER acquired 266,940 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Peetz Christopher CHIEF EXECUTIVE OFFICER | 2025-01-21 | Grant or award · Stock Option (right to buy) | +153,550 | 153,550 | D | ||
| Peetz Christopher CHIEF EXECUTIVE OFFICER | 2025-01-21 | Grant or award · Restricted Stock Units | +38,390 | 38,390 | D | ||
| Peetz Christopher CHIEF EXECUTIVE OFFICER | 2025-01-21 | Grant or award · Performance Restricted Stock Units | +75,000 | 75,000 | D | ||
Loading xslF345X05/form4-01232025_100149.xml…